ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0090336;positive regulation of brown fat cell differentiation;7.0;1.0;0.8509193652572005;9.628524252492122;143.10318807846457;7.57984905034425;0.004789534920478337;0.738553198190834;[PRDM16, PTGS2, MAPK14]
GO:0046697;decidualization;4.0;1.0;0.75;9.628524252492122;34.68251427445171;6.781341354126479;0.0011607925405295219;0.5967981122146513;[GHSR, VDR, LIF, PTGS2, MEN1, CTSB]
GO:0090050;positive regulation of cell migration involved in sprouting angiogenesis;11.0;1.0;0.9324289523296623;9.628524252492122;645.2358217485536;6.7325511899570465;0.021595462279385098;0.7767319332797141;[NRP1, ANXA1, PLK2, HMOX1, PTGS2]
GO:0045766;positive regulation of angiogenesis;7.0;0.811012628672052;0.7564256795932265;9.303101852057495;134.49314513679974;4.7081694254602375;0.0045013645317563845;0.5916953686275062;[NRP1, ECM1, CD40, SERPINE1, ITGB2, ADM, BRCA1, AQP1, CDH5, C3AR1, CTSH, CYP1B1, ITGB8, CD34, IL10, GHSR, ANXA1, ANXA3, GAB1, SIRT1, F3, GREM1, SFRP2, IL1B, ADAM12, AGTR1, CHI3L1, ENG, CX3CR1, C5AR1, TWIST1, PTGS2, DLL1, THBS1, CXCR2, HMOX1, PLCG1, JUP, PLK2, TNFSF12, KLF4, LRG1, TEK]
GO:0097089;methyl-branched fatty acid metabolic process;8.0;0.8933024483968273;0.8216512241984136;9.4949928598676;93.73125239075797;9.083926447120524;0.0031371006648681556;0.839552420951524;[SLC27A2]
GO:0000187;activation of MAPK activity;13.0;0.811012628672052;0.8680612791036626;9.526741558182179;3706.2450018205795;4.759793790865545;0.12404468480698592;0.705971040585548;[, LRRK2, TNF, GHR, PROK2, TNFSF11, MAP4K1, MAP2K2, SYK, DUSP6, MDFIC, IL1B, KIT, TLR4, C5AR1, FPR1, CXCR4, TGFA, NOD2, IQGAP3, THBS1, NTF3, CCL19, DRD4, MAP2K6, CD74, EGF, MAPK14, BMP2, CD40LG, CDK1, CSPG4, PKN1]
GO:0050796;regulation of insulin secretion;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;205.48125160941495;4.61801832846594;0.006877272570246766;0.6324062972578516;[KCNG2, SLC2A2, TNF, SOX4, GHSR, PRKCE, IFNG, IL1B, CFTR, BLK, KCNA5, ITPR3, DPP4, CNR1, CCL5, FKBP1B]
GO:0045893;positive regulation of transcription, DNA-templated;10.0;0.5159906454948852;0.673236334608363;8.141425192250265;1208.1179641469014;2.4745772039531437;0.04043462102441837;0.5417910051506925;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, GATA1, JUN, JAG1, JUP, NR2F2, COL1A1, HOXC10, FOS, SIRT1, MMP12, CKS2, STAT4, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RUVBL2, ADCYAP1, BLM, FOXO1, ZNF423, NFKB1, CXCL10, CIITA, FHL2, HHEX, PPP1R12A, PEG3, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, CCNH, TNFSF11, SFRP2, EGR1, EGR2, EGR3, CD28, CD40, BRCA1, BRCA2, CD3D, IL10, RGMA, IL1B, YAP1, SATB2, CD74, IL17A, CD86, CD80, IHH, CCNE1, VDR, HMGA1, INHBA, IL6, BMP2, TCF4, HMGB2, ARHGEF10L, LYL1, NUP62, YWHAH, MYOCD, DDX58, ETV1, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, EGF, MAPK14, CD4, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, HOXA5, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, TGFB1I1, PAX5, PAX2, RARA, ENG, EPCAM, NR1H2, GTF2H1, POU4F1, FOSB, PF4, PLXND1, TNF, CDH1, MEN1, MAP2K2, F2R, COPS5, MAFF, BCL3, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPB, SMARCD3, CEBPE, NOD2, ABLIM3, KLF4, PML, KLF1, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, IL23A, BEX1, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EDN1, RHOG, MDFIC, TFEC, TLR4, TLR2, CDX2, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, ADRB2, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, NR4A3, SLC40A1, CKAP2, DCN, DNM2, DLL1, LUM, MEIS2, MEIS1, RBMX]
GO:0071498;cellular response to fluid shear stress;4.0;0.7980440201809971;0.6490220100904985;9.271849308553389;39.92524609926753;6.8867018697843045;0.0013362620565537933;0.6021862538851576;[MEF2C, PTGS2, KLF4]
GO:0031915;positive regulation of synaptic plasticity;8.0;0.8653626801206646;0.8076813400603323;9.446202695698167;41.65758488823441;7.57984905034425;0.0013942418768168238;0.7626338329336335;[CDC20, PTGS2, EPHB2]
GO:0032729;positive regulation of interferon-gamma production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;5.6339389012889365;0.002183412136085803;0.6112402100070131;[PTPN22, CD3E, TNF, PYCARD, PDE4B, IL6R, CCR2, HLA-DPA1, HAVCR2, SLC11A1, IL23A, IL1B, LTA, TLR8, TLR7, TLR4, HSPD1, KLRK1, CD14, IL12RB1, IL12RB2, FZD5, CD2, BCL3, HLA-DPB1, IL18R1, CD244]
GO:0051926;negative regulation of calcium ion transport;8.0;0.7140352122741334;0.7320176061370667;8.890925309361343;69.46225493434336;5.666199763507158;0.0023248391606816524;0.6647697194109919;[FMR1, PTGS2, PLN, DRD4, TGFB1, LILRB1, LILRB2, GEM, FKBP1B]
GO:0010656;negative regulation of muscle cell apoptotic process;8.0;0.8436909121759173;0.7968454560879586;9.485423408851448;104.61422944852276;6.250713103064308;0.003501344112948074;0.6946617587785947;[MYOCD, EDN1, ADCYAP1, SFRP2, HMOX1]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0070206;protein trimerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.8650506222523235;0.00140677858073304;0.6230592741648748;[MGST1, TCL1A, NUP62, EMILIN1, CD74, ARG1, MIF, COL1A1, COL1A2, COL6A2, NUP54, CD247]
GO:0033138;positive regulation of peptidyl-serine phosphorylation;10.0;0.9326813400603323;0.8815816818910864;9.59573442966913;778.6672313762616;5.152100814396198;0.026061291479152104;0.6787196871063318;[IFNA5, IFNA4, IFNA7, IFNA2, IFNA8, TNF, TCL1A, AKT1, IFNA14, IFNA16, MIF, SFRP2, IFNG, IFNA10, PTGS2, PAK1, NTF3, IFNA21, SNCA, TGFB1, CAV1, LIF, IL6, CAMK1]
GO:1902042;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;10.0;0.9326813400603323;0.8815816818910864;9.589303539338841;425.73912115989816;6.193554689224359;0.014249105244888325;0.731979686697602;[SERPINE1, HMGB2, TNFAIP3, FASLG, BRCA1, HMOX1, DAPK1, TNFRSF10B, SFRP2]
GO:0016239;positive regulation of macroautophagy;8.0;0.7671156992804218;0.7585578496402109;9.242861771680136;266.06548500403863;5.666199763507158;0.008904972339694651;0.6647697194109919;[ADRB2, HMOX1, TSC2, SIRT1, DCN]
GO:0043518;negative regulation of DNA damage response, signal transduction by p53 class mediator;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;408.0520127891259;7.138016298065211;0.013657133645082668;0.7612791106150483;[CD74, TWIST1, SNAI2, MIF, SIRT1]
GO:0042307;positive regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;778.7460608588023;6.063501560976162;0.02606392983099081;0.706328376990269;[LRRK2, PTGS2, CDH1, ECT2, TGFB1, JUP, PRKCD, MAPK14, IFNG, CDK1]
GO:0007264;small GTPase mediated signal transduction;6.0;0.7369933605727446;0.6916169928765168;8.741221057491218;26.42836680105094;4.015022244900292;8.845336528452411E-4;0.5284487369119741;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK3, AGTR1, RIN2, IQGAP3, RASGRP4, HMOX1, JUN, HACE1, PLK2, DHCR24, ARHGAP30, COL1A2, BCL6, RGL4, RGL1, LAT, DOCK5, CDKN1A, DOCK4, ARHGAP6, ARHGAP4, RAC2, RALGPS2, ARHGEF12, CHUK, RHOG, RHOH, VAV1, RAB33B, CCNA2, RHOU, RAB21, PAK1, PDPN, EPS8L1, DNAJA3]
GO:0034220;ion transmembrane transport;5.0;0.44800904580126355;0.514245534761552;6.183841758890227;26.332710660334534;2.96803432163749;8.813321279004005E-4;0.4420264250971726;[SLC35B3, AQP9, SLC4A1, SLC4A3, PHB2, AQP1, SCN1A, SLC6A16, SLC11A1, SLC6A15, PRKCE, CACNA2D3, SLC6A13, CLDN4, COX7A2L, KCNQ1, CFTR, SLC22A4, TTYH3, TTYH2, ATP5J, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, GJC1, ANKH, KCNMB3, KCNN3, SCN3A, ABCA1, SLC6A6, SFXN3, FXYD6, GABRB1, COX7B, GRIK3, SLC7A11, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, SLC7A5, SLC7A7, SLC7A8, CLDN17, SGK1, CAPS2, SLC43A2, KCNA5, COX5B, COX5A, ANO10, SLC17A6, CCL19, GABRE, SLC17A3, CCL21, SLC31A2, GABRA5, COX6C, FKBP1B, RHAG, KCNG2, STEAP3, STEAP4, ATP8A1, DENND5B, COX6A1, SLC8A1, SLC26A11, SLC16A3, KCNH1, KCNH2, CHRNB4, SLC38A1, F2R, ATP11C, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, SLC38A11, ITPR3, CACNA1F, SLC1A6, SLC38A6, CYC1, SLC15A3, CLCA4, GRIA4, PTPRC, SLC26A8, SLC26A7, SLC26A3, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, ASPH, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, SLC3A1, LRP2, ATP2C2, SLC12A2, SLC35A3, NDUFA4, SLC12A1, KCNJ15, KCNJ16, SLC4A7, P2RX5, P2RX1]
GO:1902166;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;11.0;1.0;0.9324289523296623;9.628524252492122;2131.9864477698584;7.212124270218933;0.07135566774362433;0.8012573229067359;[CD74, TAF9, MIF, SIRT1]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:0042264;peptidyl-aspartic acid hydroxylation;9.0;0.9326813400603323;0.8625812952104552;9.574457031221845;309.91140740841894;9.083926447120524;0.010372455903800976;0.8607930461318132;[ASPH]
GO:0008631;intrinsic apoptotic signaling pathway in response to oxidative stress;7.0;0.8653626801206646;0.7836007053175329;9.523163736834295;52.930841574252625;6.943860283624253;0.001771547632825523;0.7060287030842711;[PRKCD, PML, MELK, CYP1B1]
GO:0046466;membrane lipid catabolic process;6.0;0.7307253602413294;0.6884829927108091;9.176539128749065;159.2067488982067;6.409777797693995;0.005328506608851286;0.6509166472493662;[FUCA1, GM2A, CYP1B1]
GO:0008630;intrinsic apoptotic signaling pathway in response to DNA damage;7.0;0.9326813400603323;0.8172600352873667;9.55953138100517;84.23129647150353;5.54296712308321;0.002819145689655962;0.6343869617060081;[CDKN1A, BCL2A1, BRCA1, BRCA2, TNF, PYCARD, E2F1, HMOX1, SFN, MLH1, TNFRSF1B, SIRT1, PML, MSH6, MSH2, BCL3, EPHA2]
GO:0042542;response to hydrogen peroxide;5.0;0.9326813400603323;0.7565816818910864;9.541512875502493;79.2907140195247;5.09494240055625;0.0026537888412237636;0.5507966031644187;[HP, TNFAIP3, SLC8A1, AQP1, IL18RAP, MYB, CYP1B1, PDGFRB, ANXA1, DUSP1, ARG1, PRKCD, SIRT1, PAX2, ADAM9, PCNA, KCNA5, FOXO1, PDGFD, HMOX1, ECT2, JUN, KLF4, COL1A1, IL6, NR4A3, FKBP1B, CDK1, SDC1, EZH2]
GO:0006699;bile acid biosynthetic process;8.0;1.0;0.875;9.628524252492122;493.34951140512965;6.481236761676141;0.01651196416099542;0.7064507494004503;[OSBPL7, HSD17B4, CH25H, SLC27A2]
GO:0001561;fatty acid alpha-oxidation;9.0;1.0;0.896240625180289;9.628524252492122;579.9307786885206;7.697632086000634;0.019409761258888828;0.7898978880348613;[SLC27A2]
GO:1903779;regulation of cardiac conduction;7.0;0.6913464685778243;0.6965925995461126;8.763526815005518;28.828680454715183;5.788089581116195;9.648699906913433E-4;0.6469225356091749;[CAMK2D, ATP2A3, ITPR3, SLC8A1, FLNA, CXADR, CAV1, TRPC1, EHD3, ASPH, FKBP1B]
GO:0045657;positive regulation of monocyte differentiation;9.0;1.0;0.896240625180289;9.628524252492122;840.3783565179247;7.57984905034425;0.02812670730123667;0.7838744581139225;[CD74, CD4, JUN, ACIN1]
GO:0001676;long-chain fatty acid metabolic process;8.0;0.6835726970475526;0.7167863485237763;8.866384200445225;93.73125239075797;5.049685808968129;0.0031371006648681556;0.6332411671050352;[, CYP1B1, ACSL1, CYP4A11, ACSL5, ELOVL6, ACSBG1, SLC27A3, SLC27A2, HSD17B4, PTGS2, CYP3A4, PTGS1, ALOX5, PNPLA8, CYP4F2, CYP4F3, CYP4F12, TBXAS1, PLP1]
GO:0048016;inositol phosphate-mediated signaling;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.814661162170232;6.599019797332524;9.309316775279788E-4;0.6883935445785896;[EDN1, ITPR3]
GO:1990776;response to angiotensin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;7.138016298065211;0.0024778305216419678;0.7159578506919597;[PRKCD, CDC6, PTGS2, SLC30A10, NFKB1]
GO:0071243;cellular response to arsenic-containing substance;4.0;0.8653626801206646;0.6826813400603323;9.377209824211215;38.7152913866576;7.138016298065211;0.0012957659612112835;0.6150384854347593;[HMOX1]
GO:0030890;positive regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.1565706318756;6.063501560976162;0.016940604907709607;0.706328376990269;[CDKN1A, CD40, TFRC, TNFSF13B, NCKAP1L, CD74, MEF2C, FCRL3, MIF, MSH6, BST1, PTPRC, BCL6, CARD11, CD320]
GO:0016242;negative regulation of macroautophagy;8.0;0.7866048967936545;0.7683024483968273;9.283683766200392;266.4734130419696;6.343086423195323;0.0089186253240128;0.6993857346658935;[LRRK2, AKT1, HMOX1, TSC2]
GO:0031622;positive regulation of fever generation;9.0;0.8436909121759173;0.8180860812682478;9.454170865347344;276.00155245721845;7.8311634786251565;0.009237523575472428;0.7967266896635242;[CNR1, IL1B, TNFSF11, TNFRSF11A, PTGS2, TNF]
GO:0016125;sterol metabolic process;5.0;0.7090535922965819;0.6447678080092112;8.712233520617966;52.055674199354506;4.901876304479318;0.001742256568387185;0.5409231940325527;[CYP1B1, CUBN, CH25H, CFTR, ABCA1, DHCR24]
GO:0071407;cellular response to organic cyclic compound;5.0;0.5310727365277519;0.5557773801247963;7.0299582842316;63.0333181336412;3.907776714546695;0.0021096684316296343;0.4900848947730398;[IL1RN, AQP9, IFIT1, AQP1, LGALS1, AKT1, CYP1B1, MEF2C, KCNQ1, CFTR, ABCB4, ABCA1, EGR1, JUP, COL1A1, ID1, NOX4, EZH2, GABRB1, BRCA1, IFIH1, IL10, EDN1, ANXA1, ARG1, IL1B, PTAFR, PTGS2, GNAI1, CTNNA1, P2RY13, POU4F1, TNC, TNF, SLC8A1, CDH1, RUVBL2, IGFBP5, ADCYAP1, BLM, FECH, FOXO1, CCNB1, OSBPL7, TGFB1, CAV1, INHBA, NFKB1, NFKBIA, BMP2, KIF18A, NR4A3, ALPL, SLC26A3, LRRK2, PDE4B, DDX58, DNM2, CCNA2, COLEC12, CEBPB, NOD2, P2RY6, CCL5, CCL2, SNCA, KLF4, RAD51, KLF5]
GO:0010025;wax biosynthetic process;5.0;1.0;0.7902410118609202;9.628524252492122;48.507873343502226;8.390779266560578;0.0016235148665552843;0.7193458537639684;[FAR2]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0008285;negative regulation of cell proliferation;5.0;0.5619039856592722;0.5711930046905564;7.31175452450612;43.614270733588945;3.2818080717434612;0.0014597303911579066;0.4580728292695636;[SPARC, SPINT2, PHB2, CYP1B1, EPHB1, SOX7, SOX4, MEF2C, EREG, SFRP4, SFRP2, SPINT1, BTK, GATA3, GATA1, INPP5D, HMOX1, SFN, LYN, JUN, BCL11B, FZD5, LIF, CDC6, NR2F2, NOX4, SNAI2, CDKN1A, TNFRSF13B, TGFB1I1, ADM, PRL, PTPRK, BRCA2, LRRC32, TIMP2, CTLA4, CD33, HAVCR2, IL10, DUSP1, ARG1, PAWR, PDCD1LG2, CBFA2T3, NME1, CEACAM1, IL1B, RARA, TLR2, PTGS2, ASCL2, PAK1, GPNMB, FRZB, PDPN, CTNNA1, CCL23, CDKN2C, LILRB1, LILRB2, PODN, SULF1, FAP, FABP7, DLC1, PKN1, CD86, CD80, SIRPG, IHH, TNF, CDH5, DACH1, MEN1, IGFBP5, IGFBP3, F2R, TPM1, TSC2, ADCYAP1, HGS, CD274, CSF1R, CUL5, FBLN1, CNN1, NACC2, IGFBP7, TGFB2, TGFB1, RARRES3, CAV2, VDR, CAV1, HMGA1, DHCR24, INHBA, IL6, BMP2, BCL6, OGN, TNFAIP3, CXCL1, DUSP10, ADAMTS1, NUP62, PTGIR, MYOCD, AXIN2, TGFBR3, GREM1, TFDP1, IFNG, ASPH, LTA, XCL1, PDE5A, CEBPB, DLL1, THBS1, CCL8, E2F1, CCL2, ZNF503, CSK, E2F7, KLF4, PML, MEIS1, DNAJA3, PMP22, CD9, PTPN6, MNDA, FCGR2B]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, LTBR]
GO:0045786;negative regulation of cell cycle;5.0;0.5089359064165209;0.5447089650691808;7.0970975870692286;42.34575940812408;3.5270983854209863;0.0014172744586806725;0.47061698731819834;[EHMT2, SMC3, UXT, CHEK1, FBXO5, PRKACB, SOX4, MIF, AURKAIP1, GATA3, TP53BP2, SFN, BARD1, PLK2, PLK1, LIF, CDC6, NR2F2, ZWINT, STAG2, EZH2, TOP2A, CDKN1A, PTPRK, BRCA1, BRCA2, BMI1, TIMP2, IL10, DUSP1, GAS1, PCNA, PTGS2, GPNMB, CDKN2C, LILRB1, CENPF, FAP, SIPA1, MAD2L1, ZWILCH, GMNN, BUB1B, TNF, KNTC1, MEN1, MSH6, ADCYAP1, MSH2, BLM, CUL5, CCNB1, NACC2, NAE1, GAS2L1, MAP2K6, FANCI, TGFB2, TGFB1, DHCR24, INHBA, NR4A1, BMP2, BCL6, CNOT3, JMY, CDK1, TNFAIP3, HHEX, TOPBP1, MYOCD, H2AFX, SMC1A, TFDP1, IFNG, DTL, PPP1R15A, THBS1, AURKB, RBBP8, E2F1, CCL2, BUB1, E2F7, RRM2, DONSON, MAPK14, KLF4, PML, WEE1, RAD51]
GO:0046598;positive regulation of viral entry into host cell;8.0;0.9326813400603323;0.8413406700301662;9.548481544818586;85.02443603688559;7.57984905034425;0.0028456913571300335;0.7626338329336335;[CD74, CD4, LGALS1]
GO:0022900;electron transport chain;4.0;0.7140352122741334;0.6070176061370667;8.475844742553736;29.758801740447502;4.623782033182691;9.96000313069993E-4;0.48646042820481683;[COX6A1, LOXL2, COX6B1, POR, COX7A2L, UQCRC1, NDUFB10, UQCRB, UQCRH, CYC1, UQCRQ, P4HA2, NOX4, COX7B, ETFA, COX7C, UQCRFS1, COX8A, NDUFC2, NDUFS8, NDUFS7, ASPH, NDUFS6, NDUFS4, NDUFS3, NDUFB7, NDUFB6, NDUFB4, NDUFB3, NDUFB2, NDUFB1, UQCR10, COX5B, COX5A, SNCA, NDUFA8, NDUFA7, NDUFA6, NDUFA4, NDUFA3, NDUFA2, COX6C, NDUFAB1]
GO:1902219;negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress;10.0;0.9326813400603323;0.8815816818910864;9.596775554177542;756.2955759145742;8.16763571524637;0.025312532304032187;0.8329342821725234;[PTGS2]
GO:0090271;positive regulation of fibroblast growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;76.08155514529764;8.67846133901236;0.002546381181758862;0.7669372290569613;[PTGS2]
GO:0006788;heme oxidation;7.0;1.0;0.8509193652572005;9.628524252492122;126.9332679816834;9.083926447120524;0.004248342246822363;0.8154717862087246;[HMOX1]
GO:0043524;negative regulation of neuron apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.245532000236016;179.62959498689688;4.864418741944418;0.006012040888071555;0.6237666006816429;[NRP1, CHL1, MEF2C, F2R, MSH2, NAIP, CEBPB, LRP1, C5AR1, SLC30A10, CORO1A, NTF3, CCL2, HMOX1, FYN, SNCA, JUN, WFS1, GABRA5, POU4F1, NR4A2, NR4A3]
GO:0048661;positive regulation of smooth muscle cell proliferation;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;63.45804869205661;5.433268205826786;0.002123883781187112;0.6009779013089371;[TNF, MYB, AKT1, SKP2, IL6R, PDGFRB, IL10, EDN1, IGFBP5, MMP2, MMP9, EREG, HBEGF, CALCRL, PTAFR, PTGS2, THBS1, GNAI2, PAK1, CCL5, PDGFD, HMOX1, ELANE, JUN, IL6, NR4A3]
GO:0002455;humoral immune response mediated by circulating immunoglobulin;7.0;1.0;0.8509193652572005;9.628524252492122;48.293467131004675;8.390779266560578;0.001616338883576055;0.7800242071602487;[EXO1, BCL3, HLA-DQB1]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, HMOX1, LYN, EIF2S1, CXCL10, TFEC]
GO:0048146;positive regulation of fibroblast proliferation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;63.74573076450893;5.825829909099042;0.0021335122412550348;0.6210535250702663;[CDKN1A, PDGFA, BMI1, AQP1, CCNB1, PDGFD, MYB, PDGFC, E2F1, PDGFRB, PDGFRA, CD74, JUN, TGFB1, FN1, CDC6, MIF, PML, EREG, BTC, CCNA2, NDUFS4]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, HLA-DPA1, ANXA1, IFNGR1, FOS, SIRT1, F3, FCER2, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, HLA-DRA, MYD88, CIITA, ITGAM, ITGB2, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL1, BIRC5, LCP1, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, FCGR1B, PML, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, TNFSF11, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, GP1BA, IL17RB, VAV1, HCK, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR2, CD74, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, TGFB1, VCAM1, NFKBIA, IL6, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, CAMK2D, SAMHD1, NCAM1, CD4, LTBR]
GO:0051384;response to glucocorticoid;7.0;0.7671156992804218;0.7344772148974115;9.223059144383958;62.73690238121479;4.800339885259895;0.00209974766315278;0.5964089702280253;[CDKN1A, IL1RN, SPARC, ADM, TNF, AQP1, ALAD, IL10, GHSR, EDN1, ANXA1, DUSP1, ANXA3, ARG1, CAD, AVPR1A, FOS, ADCYAP1, IL1B, ADAM9, ACSBG1, PCNA, FECH, ABCB4, PTAFR, PTGS2, FOXO1, IGFBP7, TGFB1, IL6, ALPL, SDC1, FOSB]
GO:0071276;cellular response to cadmium ion;6.0;1.0;0.8231203125901445;9.628524252492122;78.50383844342444;6.139487467954083;0.0026274528238337297;0.6370939872166814;[JUN, GSN, CHUK, FOS, MMP9, AKT1, HMOX1]
GO:2000377;regulation of reactive oxygen species metabolic process;5.0;0.660418147677249;0.6204500856995447;8.475844742553736;26.78229071161683;4.7018998124466425;8.963791676210415E-4;0.5306963869301438;[PID1, HP, TNF, CLU, AKT1, CYP1B1, CD177, PDGFRB, PRKCD, AGTR1, FPR2, SLC30A10, FOXO1, KLRK1, TGFB1, AGXT2, CAV1, BST1, NOX4, CDKN1A, ITGAM, ITGB2, BRCA1, RAC2, CD36, CD34, IL10, EDN1, SYK, PAX2, DNM2, IFNG, IL1B, TLR6, TLR4, PTGS2, THBS1, GNAI2, SNCA, GCH1, MAPK14, KLF4, PTX3]
GO:0071318;cellular response to ATP;7.0;1.0;0.8509193652572005;9.628524252492122;523.2473722673394;7.212124270218933;0.01751261865772571;0.7197477358342742;[PTGS2]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, MIF, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, GH1, CD4, IL6, CSPG4, CD24]
GO:0050852;T cell receptor signaling pathway;10.0;1.0;0.9152410118609203;9.628524252492122;219.43154282413207;4.981283082083729;0.007344176262756358;0.6699840603320352;[DENND1B, ITK, TRAC, CD3G, PTPN22, CD3E, CD3D, GRAP2, TRBC1, PDE4B, ICOSLG, HLA-DPA1, CHUK, THEMIS, LIME1, ZAP70, LCK, BTK, PRKCQ, LCP2, CARD11, HLA-DQB1, HHLA2, GATA3, THY1, PAK1, INPP5D, FYN, CSK, PLCG1, HLA-DQA2, HLA-DQA1, PAG1, EIF2B3, HLA-DRB4, TRAT1, BMX, NFKB1, CD4, PTPRC, CD28, HLA-DPB1, HLA-DRA, CD247, LAT, HLA-DRB1]
GO:0008210;estrogen metabolic process;6.0;0.8933024483968273;0.7697715367885581;9.4949928598676;78.56989776551285;6.599019797332524;0.002629663769894499;0.6605944919115335;[PDGFRA, HSD17B4, CYP1B1]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[BIK, PLAUR, MMP9, PYCARD]
GO:0042167;heme catabolic process;7.0;0.8259837884571596;0.7639112594857803;9.464221201200845;638.5210787907555;7.8311634786251565;0.02137072587546392;0.7514054297404357;[BLVRB, HMOX1]
GO:0035094;response to nicotine;4.0;0.9326813400603323;0.7163406700301662;9.446202695698167;26.17342148764107;5.926926025970411;8.760008626412986E-4;0.5531032725983739;[CHRNB4, EDN1, VCAM1, SLC7A11, TNF, NFKB1, CNR1, HMOX1]
GO:0033629;negative regulation of cell adhesion mediated by integrin;6.0;0.9326813400603323;0.7894609826203107;9.523163736834295;51.31823397956752;7.474488534686424;0.0017175751078840245;0.7053660038532718;[SERPINE1, CYP1B1, SNAI2]
GO:0071260;cellular response to mechanical stimulus;5.0;1.0;0.7902410118609202;9.628524252492122;56.1235610070294;5.420364800990877;0.00187840507897962;0.5674387198563348;[CD40, AQP1, CHEK1, AKT1, IL1B, TLR8, TLR7, TLR5, TLR4, ENG, PTGS2, CASP8AP2, TGFB1, TNFSF14, TNFRSF10B, NFKB1, COL1A1, LTBR, MYD88]
GO:0002503;peptide antigen assembly with MHC class II protein complex;7.0;1.0;0.8509193652572005;9.628524252492122;45.61567929762514;8.67846133901236;0.0015267157346454312;0.7947362817240173;[HLA-DMA, HLA-DMB, HLA-DRA]
GO:0097755;positive regulation of blood vessel diameter;7.0;0.7508913569872202;0.7263650437508107;9.0689084645567;39.67967046252893;5.845247994956144;0.0013280428609958766;0.6498456195510879;[DOCK5, CALCA, DOCK4, GCH1, PTAFR, ADM, ADRB2, ADCYAP1, EDNRB, HMOX1, PTGDR]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, FCGR2B, IL13RA2, HLA-DQB1]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, CDC6, AZU1, NOX4, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, CKS2, HBEGF, ENG, CCL13, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CCNT2, FMR1, TNF, CLU, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, PTPRC, CDK1, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, CYR61, XCL1, LCP2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, CCR1, EGR1, LIF, PTK2, MARCO, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, GNAI2, PAK1, CD74, CD40LG, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0002506;polysaccharide assembly with MHC class II protein complex;6.0;1.0;0.8231203125901445;9.628524252492122;58.63041707748974;9.083926447120524;0.0019623072956339374;0.7876727335416686;[HLA-DRA, HLA-DRB1]
GO:0097756;negative regulation of blood vessel diameter;7.0;0.7436939687323844;0.7227663496233927;9.0689084645567;39.67967046252893;6.113511981550823;0.0013280428609958766;0.663564652301091;[EDN1, CAV1, PTGS2, SLC8A1, ACTA2, EDNRA, EDNRB, P2RX1]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, PRTN3, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, IL1B, KIT, PECAM1, XCL1, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0032496;response to lipopolysaccharide;5.0;0.8933024483968273;0.736892236059334;9.446202695698167;64.414971589946;4.086714173356409;0.002155911129404774;0.4992357647380114;[CD86, IL1RN, SPARC, CD80, SERPINE1, CXCL13, LOXL1, PYCARD, EDNRB, GHSR, CD96, MEF2C, SLC11A1, CD180, F2R, KMO, SLPI, ADAM9, S100A8, CD274, ABCB4, C5AR1, MGST1, LY96, CSF2RB, TNFRSF11A, KLRK1, STAP1, NLRP3, S100A14, CD14, ELANE, ABCA1, JUN, VCAM1, DEFA4, TNFRSF10C, TNFRSF10B, DEFA1, PPBP, SELE, NFKB1, SELP, CXCL10, CXCL11, IL6, ALPL, CXCL6, CXCL9, CD40, HMGB2, TNFAIP3, CXCL1, TREM2, FASLG, PTPN22, ADM, CXCL3, CXCL2, CXCL5, ALAD, THBD, DUSP10, PDE4B, CTSG, CCR7, CD36, CCR5, HAVCR2, IL10, PTGIR, EDN1, CHUK, ARG1, IRAK3, PDCD1LG2, FOS, TNFRSF1B, DCN, IL1B, LTA, RARA, TLR4, CX3CR1, CEBPB, CEBPE, PTGER2, PTGS2, CNR1, CCL2, IL12RB2, SNCA, GCH1, CCL20, NR1H2, LILRB1, LILRB2, MAPK14, CD6, LTBR, PF4]
GO:0002906;negative regulation of mature B cell apoptotic process;11.0;1.0;0.9324289523296623;9.628524252492122;225.7390073925085;8.390779266560578;0.007555281425510346;0.8615337942327104;[CD74, MIF]
GO:0030199;collagen fibril organization;5.0;1.0;0.7902410118609202;9.628524252492122;53.964823970696955;5.9928839937622085;0.0018061540931107725;0.5967173779995258;[TGFB2, COL14A1, LUM, COL11A1, COL12A1, LOXL2, COL1A1, GREM1, COL3A1, SFRP2, COL1A2, COL5A1, COL5A2, CYP1B1]
GO:0009750;response to fructose;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;32.95598622603122;7.697632086000634;0.001103007200523252;0.7445766281117727;[PTGS2]
GO:0034395;regulation of transcription from RNA polymerase II promoter in response to iron;11.0;0.8933024483968273;0.8790801765280758;9.533214072687796;252.6466751378032;9.083926447120524;0.00845585684961658;0.8969813732811862;[SLC40A1, HMOX1]
GO:0042572;retinol metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;118.00963323224862;6.375876246018314;0.003949676222508656;0.722303232910233;[DGAT2, TTR, ALDH1A1, CYP1B1]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[NUP62, MCCC2, CHRNB4, CLDN3, COL6A2, NUP54, NLGN1, ITPR3, CTNNA1, CD74, RRM1, JUP, GCH1, COL1A1, COL1A2, P2RX1]
GO:0042574;retinal metabolic process;9.0;1.0;0.896240625180289;9.628524252492122;79.50217411028933;7.212124270218933;0.0026608662201599294;0.7650689957573628;[CYP1B1]
GO:0038195;urokinase plasminogen activator signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;9.083926447120524;8.87013979980389E-4;0.7876727335416686;[PLAUR]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[HMGB2, TWIST1, GATA3, MYOCD, TGFB1, EGF, PLAUR, KLF4, MMP9, POU4F1, NME1, IFNG]
GO:0043542;endothelial cell migration;7.0;0.7980440201809971;0.7499413753476991;9.143016436710422;24.971868181253015;5.71663061713405;8.357859548042604E-4;0.6432681208679463;[NRP1, PLXND1, ITGB2, CXCL13, LOXL2, DPP4, CYP1B1, EGR3, TNFSF12, PTK2, GREM1, NR4A1, FAP, ID1, S100P]
GO:0006886;intracellular protein transport;8.0;0.5537205960740763;0.6518602980370382;8.117066748418225;90.55259897265384;3.0436717358431102;0.0030307139955665606;0.5306535141162272;[, NUP107, PHB2, AKT1, HOMER3, WLS, NUP85, NUP88, MMP12, CSE1L, TNF, CLU, LAMP2, AP2M1, RAB32, SLC27A2, EVI5, BCL6, BCL3, NLGN1, UNC93B1, RAB21, PML, VPS41, IFIT1, ARFIP1, EGR2, POLA2, CD24, AKAP12, XPO1, TMED6, SYK, RAB33B, HSD17B4, STX11, RANBP2, RANBP1, CD74, RANBP6, NUPL2, RAMP1, SCARB2, TSC2, ATP1B1, HGS, COPB2, TGFB1, NUP155, NFKBIA, TBCK, NUP62, YWHAH, NUP133, TBC1D9, IFNG, EHHADH, NUP54, HSPD1, NUP35, RAN]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[PLAU, PROS1, SERPINE1, PLAUR, SERPING1, GP1BA]
GO:0051290;protein heterotetramerization;7.0;1.0;0.8509193652572005;9.628524252492122;85.45061507946225;6.444869117505266;0.002859955186148837;0.6805102716434839;[CD74, NLGN1, RRM1, NUP54]
GO:0043305;negative regulation of mast cell degranulation;11.0;0.9326813400603323;0.8987696223598284;9.607470843294289;1077.1478631716955;7.9853141584524145;0.03605116961021663;0.8407982897480031;[HMOX1, IL13RA2]
GO:0006879;cellular iron ion homeostasis;10.0;0.8436909121759173;0.837086467948879;9.474373572664863;186.73793370626092;5.69953618377475;0.006249950587919157;0.706715557354699;[ALAS2, TFRC, ABCB6, SLC40A1, HEPH, HMOX1, SLC11A1, CYBRD1, TF, LCN2, LTF, ABCG2]
GO:0002830;positive regulation of type 2 immune response;6.0;0.8933024483968273;0.7697715367885581;9.461470167828956;108.5833891387084;7.069023426578259;0.0036341883157667808;0.6846304993685643;[CD86, CD74, IL6, RSAD2, RARA, NLRP3, XCL1, GATA3, NOD2]
GO:0050873;brown fat cell differentiation;5.0;1.0;0.7902410118609202;9.628524252492122;21.75937296335754;6.444869117505266;7.282666309192915E-4;0.6198319182472036;[CEBPB, LAMB3, ADRB2, PTGS2, ALDH6A1, LRG1, PRDM16]
GO:0043392;negative regulation of DNA binding;5.0;0.7586651285174919;0.6695735761196662;8.866384200445225;32.533753988449135;5.788089581116195;0.0010888754675157227;0.5862441822128946;[GATA1, E2F1, HMOX1, JUN, NFKBIA, ID1]
GO:0006635;fatty acid beta-oxidation;9.0;0.811012628672052;0.801746939516315;9.464221201200845;579.9307786885206;5.734022359845919;0.019409761258888828;0.6894787953221185;[HSD17B4, ETFA, ACAT1, ACADM, HIBCH, EHHADH, SLC27A2]
GO:0043030;regulation of macrophage activation;6.0;0.8259837884571596;0.7361122068187242;9.377209824211215;27.112248267214866;6.088194173566533;9.074225500643868E-4;0.63447084575632;[ITGAM, LRRK2, ITGB2, THBS1, HSPD1, STAP1, HAVCR2, SNCA, IL10, CD74, MIF, BPI, TLR6, FCGR2B, TLR4, CD200]
GO:0097202;activation of cysteine-type endopeptidase activity;12.0;1.0;0.9481203125901445;9.628524252492122;669.1123145181327;7.212124270218933;0.0223945870049345;0.8169486831672182;[ASPH, PERP]
GO:0043154;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;12.0;0.8653626801206646;0.8808016526504769;9.556203590912496;734.4861809891323;5.277263957350204;0.024582591483058774;0.7179998367869053;[TNFAIP8, AQP1, RPS6KA1, AKT1, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, POR, SFRP2, BIRC5, NAIP, IFI6, NLRC4, PTGS2, THBS1, SFN, SNCA, TNFSF14, TNFRSF10C, TNFRSF10B, DHCR24, KLF4]
GO:0060291;long-term synaptic potentiation;8.0;1.0;0.875;9.628524252492122;145.7697243391103;5.948432231191374;0.004878781489395318;0.6792031009335148;[SLC24A2, SLC24A1, NLGN1, PLK2, ITPR3, TNR, SHANK3, SNCA]
GO:0051209;release of sequestered calcium ion into cytosol;14.0;0.7980440201809971;0.874941375347699;9.527428135620752;522.9340415463636;5.9928839937622085;0.01750213176047399;0.7823957313958061;[CCL21, PRKCE, F2R, FASLG, ITPR3, JPH2, PTPRC, LCK, FKBP1B, XCL1, CCR7, CCL19, CCR5]
GO:0051968;positive regulation of synaptic transmission, glutamatergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.83014596643335;6.375876246018314;0.004546112746301595;0.701062607729944;[ADCYAP1, NLGN1, TNR, PTGS2, KMO, SHANK3]
GO:0071456;cellular response to hypoxia;6.0;1.0;0.8231203125901445;9.628524252492122;103.24589989147204;5.104244793218563;0.0034555473540902374;0.5841516286869992;[SUV39H1, MPL, PHB2, SLC8A1, AQP1, AKT1, EDN1, KCND2, PRKCE, SIRT1, CCNA2, TWIST1, PTGS2, CCNB1, E2F1, HMOX1]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, VNN1, CXCL12, SNAI2, GRINA]
GO:0032764;negative regulation of mast cell cytokine production;8.0;1.0;0.875;9.628524252492122;311.05347994333346;9.083926447120524;0.010410680043746014;0.839552420951524;[BCL6, HMOX1]
GO:0010575;positive regulation of vascular endothelial growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;64.54350789155374;6.481236761676141;0.002160213123744424;0.6545710619905948;[TGFB1, C5AR1, BRCA1, PTGS2, SULF1, SULF2, IL1B, C3AR1, CYP1B1, HPSE]
GO:0007186;G-protein coupled receptor signaling pathway;5.0;0.5508212674310002;0.5656516455764204;7.20077601654407;23.17027026302992;2.605416804911955;7.75488093814194E-4;0.4234821484283897;[MRGPRF, EDNRA, EDNRB, GPR171, C3AR1, AKT1, PROK2, HOMER3, PRKACB, PTGDR, TAS2R10, TAS2R13, TAAR2, TRHR, EREG, TIAM2, SFRP4, ADCY9, SFRP2, AGTR1, FPR1, FPR3, FPR2, OR7D2, CCR10, CCR1, ABCA1, FZD1, GPR15, FZD5, OR2J2, FZD8, AZU1, NMBR, PPBP, MARCO, PNOC, OR7C2, GPR18, GPR19, GPR25, GABRB1, GRIK3, ADM, CD3E, AKAP12, CCR9, RAC2, FFAR2, CCR7, CCR6, CCR5, CCR2, EDN1, GPR37, ANXA1, RHOG, GPBAR1, TACR3, AGTRAP, PTH2R, GP1BA, AVPR1A, SORCS3, VAV1, MC3R, CCL13, PTGER2, PTAFR, CXCR5, CXCR4, CXCR6, GNAI1, GNAI2, FGD3, FGD4, CXCR1, FRZB, NPY, CXCR2, FLNA, CCL19, GABRE, CCL18, GPR157, P2RY13, GABBR1, CCL23, CCL21, SORT1, GABRA5, CCL20, P2RY14, GPR6, RAMP1, LGR4, F2RL3, PF4, CHRM2, CHRM1, CELSR1, CXCL13, CXCL16, RGS1, CCRL2, PDGFRB, CD97, GHSR, LHCGR, SPNS3, APLP2, F2R, NPY1R, DGKZ, ADCYAP1, SPNS1, OR2C3, CALCA, SUCNR1, CALCRL, GPR87, C5AR1, GPR85, ITPR3, GPR84, ADRB2, GPR82, HRH4, PSAP, ECT2, DRD4, HTR1E, CAV1, GPR98, CXCL10, CXCL11, CXCL12, GNB2, OR7E24, TAS2R7, CXCL6, CXCL9, OR1G1, CXCL1, CXCL3, CXCL2, CXCL5, GRM5, PDE4B, PTGIR, ARHGEF12, GLP2R, OR2H1, XCL1, CX3CR1, LRP1, OR1E1, P2RY6, CCL8, PLN, CCL7, CNR1, P2RY2, OR2W1, CCL5, CCL4, CCL2, S1PR3, OR12D3, CCL1, S1PR5, SLC12A2, TSHR, OR11A1, PTPN6]
GO:0031394;positive regulation of prostaglandin biosynthetic process;10.0;0.9326813400603323;0.8815816818910864;9.59462270081644;954.1434290848206;8.390779266560578;0.03193432189813256;0.8443458537639685;[ANXA1, AVPR1A, PTGS2]
GO:0032088;negative regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.61713652769816;5.420364800990877;0.009358533920496976;0.725318020585559;[TNFAIP3, PYCARD, CYP1B1, HAVCR2, IL10, CHUK, IRAK3, SIRT1, PKHD1, NLRP3, KLF4, NFKBIA, NLRP12, CCDC22]
GO:0031670;cellular response to nutrient;6.0;0.6162540371078848;0.6312473311440869;8.506381466413817;111.40291525692865;5.845247994956144;0.003728555317534849;0.6220465668840318;[ABCB4, TNC, PTGS2, HMOX1, FYN, COL1A1]
GO:0090023;positive regulation of neutrophil chemotaxis;11.0;1.0;0.9324289523296623;9.628524252492122;945.710466239641;6.343086423195323;0.03165207822087823;0.7568146869955557;[CXCL6, CD74, EDN1, CCL21, C5AR1, CXCL1, PPBP, CXCL3, CXCL2, CXCL5, IL23A, IL1B, CXCR2, C3AR1, RAC2, XCL1, CCR7, NCKAP1L, CCL19, PF4]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, C3AR1, PRKCD, RNASE3, RNASE2, BIN2, PADI2, FPR1, FPR2, GNS, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, TLR2, LILRA3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, PLAU, CD97, CHRNB4, CD93, OSCAR, DOK3, PRTN3, VCL, PSMD14, C5AR1, MGAM, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0043433;negative regulation of DNA binding transcription factor activity;11.0;0.811012628672052;0.8379352666656883;9.468181602416943;278.0076986152632;4.753193106834193;0.00930466748196786;0.6755074688592472;[TNFAIP3, PHB2, PYCARD, CYP1B1, HAVCR2, MEN1, IL10, CHUK, IRAK3, SIRT1, SFRP4, XCL1, SIK1, TWIST1, PKHD1, FLNA, NLRP3, HMOX1, WFS1, KLF4, NFKBIA, NLRP12, ID1, CCDC22, EZH2]
GO:0042102;positive regulation of T cell proliferation;9.0;0.7763722522362496;0.7844267512984139;9.424925297250882;564.8543510249671;5.212725436212633;0.018905166792893686;0.6628196464047262;[CD86, TFRC, CD80, CD3E, TNFSF13B, PYCARD, IL6R, ICOSLG, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, PDCD1LG2, ZAP70, IL23A, IL1B, XCL1, PRKCQ, CARD11, CD274, BLM, HHLA2, CD1D, CORO1A, HLA-DMB, CCL5, NCKAP1L, CCL19, IL12RB1, VCAM1, LILRB2, CD4, IL6, CD40LG, PTPRC, CD6, DNAJA3, CD28, HLA-DPB1, CD24]
GO:1904706;negative regulation of vascular smooth muscle cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;80.8833163751231;6.8867018697843045;0.0027070918088165762;0.7031056191423581;[IL10, CNN1, MEF2C, CDKN1A, MYOCD, TPM1, HMOX1]
GO:0009404;toxin metabolic process;3.0;0.5720181185523628;0.484129371866326;7.2867184463447945;27.61873557695172;6.686031174322154;9.243742245122942E-4;0.5400442577772261;[CYP1B1]
GO:0046427;positive regulation of JAK-STAT cascade;9.0;0.8933024483968273;0.8428918493787028;9.52844079393514;286.6013214379199;5.459585514144159;0.009592288304083759;0.675444082270312;[CSF1R, CD40, IFNA2, PRL, GHR, CCL5, CYP1B1, FYN, IL6R, LYN, F2R, LIF, GH1, IL6, IFNG, IL23A, KIT]
GO:0071284;cellular response to lead ion;6.0;1.0;0.8231203125901445;9.628524252492122;77.8106912628645;8.390779266560578;0.002604253811492351;0.7522251544931926;[ALAD, PTGS2]
GO:0002686;negative regulation of leukocyte migration;8.0;0.6664901433067099;0.7082450716533549;8.992535485772125;239.840353788688;6.193554689224359;0.008027240799002647;0.6917386748366816;[CCL21, MIF, GREM1, KLRK1, CXCL12, MMP28, STAP1, PADI2, CCL2, HMOX1, EMILIN1, HOXA7, GPR18]
GO:0045581;negative regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;878.9850552837634;6.088194173566533;0.029418838765156156;0.7075911583464645;[CD74, ANXA1, IFNA2, IHH, BCL6, CTLA4]
GO:0045582;positive regulation of T cell differentiation;9.0;0.7043150770688792;0.7483981637147287;9.320222892837606;861.1600055729926;5.395046993006588;0.0288222503928399;0.6721435792979885;[CD86, CD83, CD80, IHH, DUSP10, MYB, ANXA1, SYK, ZAP70, IFNG, IL23A, IL1B, RARA, GATA3, NLRP3, NCKAP1L, CCL19, IL12RB1, CD74, TGFB1, EGR3, LILRB2, VNN1, BCL6]
GO:0001516;prostaglandin biosynthetic process;11.0;0.8933024483968273;0.8790801765280758;9.597752593825367;1037.183190875448;7.138016298065211;0.03471358799433119;0.7974674377644215;[CD74, EDN1, PNPLA8, MGST1, MIF, PTGS2, PTGS1]
GO:0002606;positive regulation of dendritic cell antigen processing and presentation;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;55.28681003950749;7.8311634786251565;0.0018503997771236419;0.7236063770733796;[CD74, CCL21, SLC11A1, CCR7, CCL19, NOD2]
GO:0032355;response to estradiol;5.0;0.9326813400603323;0.7565816818910864;9.523163736834295;74.25476231829794;4.940791720728991;0.0024852400698459885;0.542913330229313;[IHH, BRCA2, CTGF, RUVBL2, PDGFRB, IL10, GHSR, ANXA1, DUSP1, TACR3, CCNA2, IL1B, RARA, PCNA, ABCB4, PTGS2, SOCS2, RBBP8, TGFB1, NR2F2, POU4F1, COL1A1, GH1, CD4, KIF18A, EZH2]
GO:0006809;nitric oxide biosynthetic process;6.0;1.0;0.8231203125901445;9.628524252492122;241.09966064176743;7.212124270218933;0.008069388666072628;0.6919486831672181;[GCH1, AKT1, CYP1B1]
GO:0030336;negative regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.20713857156096;158.04059951544355;4.3090134865453384;0.00528947663847651;0.5712825153487487;[IL1RN, SERPINE1, CXCL13, DACH1, ARHGDIB, CYP1B1, HOXA7, MEF2C, IGFBP5, IGFBP3, TPM1, MIF, SFRP2, PADI2, VCL, TACSTD2, THY1, KLRK1, STAP1, HMOX1, TGFB1, JAG1, JUP, NR2F2, CXCL12, GPR18, PTPRR, MCTP1, PTPRK, ARHGAP4, DUSP10, MMP28, EMILIN1, TIMP1, MYOCD, ARAP3, DCN, GREM1, TMEFF2, ENG, CX3CR1, LRP1, THBS1, CCL2, CCL21, TIE1, PODN, KLF4, SULF1, COL3A1, DLC1]
GO:0044539;long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;7.474488534686424;0.0025111172729558144;0.8146746435927894;[ACSL1, CD36, SLC27A2]
GO:0033280;response to vitamin D;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;74.55580141320215;6.375876246018314;0.002495315577434836;0.6769819729871445;[TGFB1, ABCB4, TNC, PTGS2, CXCL10, CD4, IL1B, ALPL]
GO:0042759;long-chain fatty acid biosynthetic process;9.0;0.7980440201809971;0.7952626352707877;9.372590878354922;458.549617088559;6.375876246018314;0.015347243016091356;0.722303232910233;[ELOVL6, PTGS2, CYP3A4, ALOX5, PLP1]
GO:1904036;negative regulation of epithelial cell apoptotic process;8.0;0.7866048967936545;0.7683024483968273;9.148951172230236;105.53052018039445;6.139487467954083;0.003532011539135699;0.6889736746265369;[WFS1, SERPINE1, TNFAIP3, GATA3, HMOX1, TEK]
GO:0045907;positive regulation of vasoconstriction;8.0;0.8933024483968273;0.8216512241984136;9.57973408832269;103.52331479149503;6.280566066213989;0.003464832181136806;0.6961884407023742;[CAV1, PTAFR, F2R, AVPR1A, PTGS2, AKT1]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[EGF, PLAUR, TGFA, FASLG, ARAP1, MMP9, EREG, NUP62, AKT1]
GO:1903589;positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis;9.0;1.0;0.896240625180289;9.628524252492122;341.3007332013115;7.57984905034425;0.01142302838952993;0.7838744581139225;[AGTR1, HMOX1]
GO:0045986;negative regulation of smooth muscle contraction;8.0;0.7508913569872202;0.7504456784936101;8.98189708756707;66.40311154199819;7.138016298065211;0.002222452384390169;0.7400384854347593;[DOCK5, CALCA, DOCK4, CALCRL, ADRB2, PTGS2]
GO:0045987;positive regulation of smooth muscle contraction;8.0;0.7671156992804218;0.7585578496402109;9.081980546124052;66.30038010178355;6.280566066213989;0.002219014055538479;0.6961884407023742;[GHSR, MYOCD, EDN1, PTAFR, F2R, TACR3, PTGS2, KIT, PROK2]
GO:0060907;positive regulation of macrophage cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;7.9853141584524145;0.010436510936514811;0.8046099625986299;[CD74, CD36]
GO:0071471;cellular response to non-ionic osmotic stress;6.0;1.0;0.8231203125901445;9.628524252492122;98.58922030228089;9.777073627680469;0.0032996924789795543;0.8231203125901445;[PTGS2]
GO:0001961;positive regulation of cytokine-mediated signaling pathway;7.0;0.7192862368539868;0.710562483684194;8.965230035081857;244.22079422365863;5.948432231191374;0.008173850198220667;0.6551224661907153;[TREM2, CD74, EDN1, IL1R1, MMP12, IRF7]
GO:0097267;omega-hydroxylase P450 pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.57984905034425;0.008476883539459374;0.8028748447945538;[CYP4F2, CYP4A11, CYP1B1]
GO:0097421;liver regeneration;6.0;1.0;0.8231203125901445;9.628524252492122;47.21654787453615;6.250713103064308;0.0015802953652264606;0.6427820713687392;[IL10, CEBPB, PCNA, TGFB1, IHH, SULF2, NFKBIA, HMOX1, EZH2]
GO:0034644;cellular response to UV;7.0;0.7980440201809971;0.7499413753476991;9.223059144383958;66.19362175939281;5.420364800990877;0.0022154409498949313;0.628117073252615;[CDKN1A, FMR1, PTPRK, AQP1, RUVBL2, CHEK1, MME, SIRT1, CDC25A, PCNA, PTGS2, AURKB, POLD1, EIF2S1, MFAP4]
GO:0070542;response to fatty acid;5.0;0.6696747006330769;0.6250783621774587;8.578702127993445;43.78950961223322;5.382624473008031;0.0014655954787213788;0.5655086777281872;[PID1, TNC, CTGF, ALAD, AKT1, FFAR2, CCR7, CD36, PTGDR, EDN1, DGAT2, ACSL1, PRKCE, NME1, TGFBR3, IL1B, TLR2, PTGER2, PTAFR, PTGS2, P2RY6, CCNB1, E2F1, CCL19, CCL21]
GO:0070301;cellular response to hydrogen peroxide;6.0;1.0;0.8231203125901445;9.628524252492122;361.02555909653125;5.682729065458369;0.012083200561052132;0.6137353412716126;[PCNA, TNFAIP3, FOXO1, AQP1, IL18RAP, PDGFD, MYB, CYP1B1, ECT2, ANXA1, ARG1, PRKCD, KLF4, SIRT1, PAX2, IL6, CDK1, EZH2]
GO:0032227;negative regulation of synaptic transmission, dopaminergic;8.0;0.8933024483968273;0.8216512241984136;9.55953138100517;135.86833888550652;8.67846133901236;0.004547391028931578;0.8188169164668168;[PTGS2, SNCA]
GO:0035336;long-chain fatty-acyl-CoA metabolic process;7.0;0.8933024483968273;0.7975705894556142;9.485423408851448;93.60244388508701;6.558197802812269;0.0031327895601034775;0.6863059058804069;[DGAT2, ACSL1, TECR, ACSL5, ELOVL6, ELOVL7, ACSBG1, FAR2]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[PLAUR, MMP9]
GO:0071636;positive regulation of transforming growth factor beta production;6.0;0.7980440201809971;0.722142322680643;9.34084218004034;65.64212018022187;6.943860283624253;0.0021969826883592772;0.6782296504172152;[LUM, MYB, XCL1, PTGS2, THBS1, CD34]
GO:0072719;cellular response to cisplatin;6.0;1.0;0.8231203125901445;9.628524252492122;120.46332589257861;8.16763571524637;0.004031799107669873;0.7408135829017477;[HMOX1]
GO:0060333;interferon-gamma-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.514393750639154;0.00101047745553359;0.6329257181104212;[CIITA, IFI30, HLA-DPA1, IFNGR1, PRKCD, HCK, IFNG, OAS1, OAS3, IRF7, HLA-DQB1, CAMK2D, PTAFR, NCAM1, FCGR1B, HLA-DQA2, HLA-DQA1, HLA-DRB4, VCAM1, PML, HLA-DPB1, HLA-DRA, HLA-DRB1]
GO:0043619;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;12.0;0.811012628672052;0.8536266269261705;9.523163736834295;532.6985892857467;7.379178354882098;0.017828942385788714;0.825491836825702;[HMOX1]
GO:0035691;macrophage migration inhibitory factor signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;9.777073627680469;0.00101047745553359;0.8509193652572005;[CD74]
GO:0090362;positive regulation of platelet-derived growth factor production;6.0;1.0;0.8231203125901445;9.628524252492122;63.8503607109938;9.083926447120524;0.0021370141114030452;0.7876727335416686;[PTGS2]
GO:0051085;chaperone cofactor-dependent protein refolding;5.0;1.0;0.7902410118609202;9.628524252492122;21.14140270213274;6.409777797693995;7.075837224132252E-4;0.618037346520142;[CD74, HSPE1]
GO:0042760;very long-chain fatty acid catabolic process;9.0;1.0;0.896240625180289;9.628524252492122;525.4628036644517;7.8311634786251565;0.017586767152828246;0.7967266896635242;[SLC27A2]
GO:0002792;negative regulation of peptide secretion;7.0;0.6181399273706679;0.6599893289425345;8.075175806709066;82.49507115094225;4.99795013456894;0.0027610357906781187;0.6065147675675062;[IFNA2, PTPN22, LRRC32, TNF, CD34, IL10, GHSR, ANXA1, RSAD2, IL1R2, F2R, BANK1, IL1B, TLR8, TLR6, NLRP3, DRD4, CD74, FN1, LILRB1, PML, NLRP12, FKBP1B, FCGR2B, LGR4]
GO:0061304;retinal blood vessel morphogenesis;5.0;1.0;0.7902410118609202;9.628524252492122;25.965694757875163;8.16763571524637;8.690484359379531E-4;0.7079342821725234;[COL4A1, CYP1B1]
GO:0019371;cyclooxygenase pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;7.379178354882098;0.008476883539459374;0.7926125360964777;[TBXAS1, PTGS2, PTGS1]
GO:0006625;protein targeting to peroxisome;10.0;0.8933024483968273;0.861892236059334;9.56183287799345;237.37488197280172;5.572381008289503;0.007944723676105511;0.7002128357670632;[EHHADH, SLC27A2, HSD17B4]
GO:0019373;epoxygenase P450 pathway;10.0;1.0;0.9152410118609203;9.628524252492122;253.27491700286936;6.686031174322154;0.008476883539459374;0.7571649570480019;[CYP4F2, CYP4A11, CYP1B1, CYP4F12]
GO:0019372;lipoxygenase pathway;8.0;0.9326813400603323;0.8413406700301662;9.567899630675686;153.6575605806622;7.138016298065211;0.005142780269808322;0.7400384854347593;[ALOX5, PTGS2]
GO:0014806;smooth muscle hyperplasia;6.0;1.0;0.8231203125901445;9.628524252492122;38.937902165230305;9.083926447120524;0.0013032165436334183;0.7876727335416686;[HMOX1]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PDGFD, PDGFC, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0043065;positive regulation of apoptotic process;7.0;0.5587538620495764;0.6302962962819887;7.806911820114386;80.91235068524658;3.3969510907807043;0.0027080635610472266;0.5246396020141064;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, ADM, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, TNF, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, PLEKHF1, FASLG, CYR61, ITGA4, TFDP1, LCK, NLRC4, CCL5, E2F1, CCL2, PML, P2RX1, MNDA, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, IFI27, SIK1, INPP5D, TP53BP2, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, IL10, VAV1, IL1B, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, LTBR]
GO:2000343;positive regulation of chemokine (C-X-C motif) ligand 2 production;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;89.02652997090885;7.8311634786251565;0.0029796378394510905;0.7514054297404357;[CD74, MIF, TNF]
GO:0034356;NAD biosynthesis via nicotinamide riboside salvage pathway;12.0;1.0;0.9481203125901445;9.628524252492122;2003.6404315682985;7.069023426578259;0.06706004208527355;0.8096304993685645;[PTGS2]
GO:0071346;cellular response to interferon-gamma;6.0;1.0;0.8231203125901445;9.628524252492122;81.6500655361772;5.266214121163619;0.0027327542132076126;0.5924347476504533;[HLA-DPA1, EDN1, DAPK1, KIF16B, XCL1, TLR4, TLR2, CCL13, STXBP2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CD58, CCL19, CCL18, IL12RB1, CCL23, GSN, CCL21, CCL20, ZYX]
GO:0045080;positive regulation of chemokine biosynthetic process;8.0;0.9326813400603323;0.8413406700301662;9.597752593825367;840.1940438043877;7.697632086000634;0.02812053852058526;0.7686572628545723;[EGR1, IL1B, HMOX1, AZU1, TNF]
